BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 30237435)

  • 1. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.
    Huang Y; Zhang K; Li Y; Dai Y; Zhao H
    Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1.
    Chen L; Wang X; Ji C; Hu J; Fang L
    Pathol Res Pract; 2020 Dec; 216(12):153231. PubMed ID: 33059240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
    Chen Y; Li Y; Gao H
    Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
    Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
    J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
    Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
    Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
    Huang T; Guan S; Wang C
    Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis.
    Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
    Gene; 2019 Jul; 705():44-50. PubMed ID: 30981837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
    Kong Q; Qiu M
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG15 promotes the proliferation of nasopharyngeal carcinoma via sponging miR-141-3p to upregulate KLF9.
    Yi TW; Lv XX; Fan H; Zan N; Su XD
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6744-6751. PubMed ID: 32633365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PFAR facilitates the proliferation and migration of papillary thyroid carcinoma by competitively binding to miR-15a.
    Fang T; Yu K
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3037-3048. PubMed ID: 37874339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
    Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
    Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.